Survey of Patients Taking IOP-Lowering Eye Drops

Survey to assess perspectives of patients prescribed IOP-lowering eye drops at a single office visit.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Glaucoma Eye Diseases Ocular Hypertension

Sex eligibility

All sexes

Study type

Observational

Primary location

ForSight VISION5 Recruitment Referral Center

Menlo Park, California, 94025, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Prescribed IOP-lowering eye drops

Exclusion criteria

Can complete survey instrument in English

Treatment and study plan

Survey

Other

Primary outcomes

Descriptive Statistics of Subject Perceptions of Different IOP-Lowering Treatments

Time frame: A Single Office Visit

Sponsors and collaborators

Lead sponsor

ForSight Vision5, Inc.

Industry

Registry information

Official study title

A Multi-Site Questionnaire-Based Study to Assess Attitudes Regarding Current IOP-Lowering Eye Drops and Products in Development for Sustained Release of Medication in Glaucomatous and Ocular Hypertensive Subjects

Important dates

Study start: 2015
Primary completion: 2015
Study completion: 2015
First posted: Mar 10, 2015
Registry last updated: Jun 11, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed